AKBULUT, H. Et Al. 2017. Tumor associated macrophages to predict the efficacy of bevacizumab plus chemotherapy in patients with advanced colorectal cancer.. 53rd Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , (Illinois, United States Of America).

AKBULUT, H., Gunay, F. S. D., Kirmizi, B. A., Koksoy, E. B., ENSARİ, A., & Icli, F., (2017). Tumor associated macrophages to predict the efficacy of bevacizumab plus chemotherapy in patients with advanced colorectal cancer. . 53rd Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America

AKBULUT, HAKAN Et Al. "Tumor associated macrophages to predict the efficacy of bevacizumab plus chemotherapy in patients with advanced colorectal cancer.," 53rd Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 2017

AKBULUT, HAKAN Et Al. "Tumor associated macrophages to predict the efficacy of bevacizumab plus chemotherapy in patients with advanced colorectal cancer.." 53rd Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America, 2017

AKBULUT, H. Et Al. (2017) . "Tumor associated macrophages to predict the efficacy of bevacizumab plus chemotherapy in patients with advanced colorectal cancer.." 53rd Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America.

@conferencepaper{conferencepaper, author={HAKAN AKBULUT Et Al. }, title={Tumor associated macrophages to predict the efficacy of bevacizumab plus chemotherapy in patients with advanced colorectal cancer.}, congress name={53rd Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)}, city={Illinois}, country={United States Of America}, year={2017}}